Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
JAMA Oncology|August 23, 2019
Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 TrialRamesh Rengan, Rosemarie Mick, Daniel A Pryma, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
The New England Journal of Medicine|July 13, 2012
Blockade of lymphocyte chemotaxis in visceral graft-versus-host diseaseRan Reshef, Selina M Luger, Elizabeth O Hexner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedsideCheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Oncoimmunology|October 6, 2018
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanomaDavid L Bajor, Rosemarie Mick, Matthew J Riese, et al.
Photodiagnosis and Photodynamic Therapy|November 9, 2017
Lesion oxygenation associates with clinical outcomes in premalignant and early stage head and neck tumors treated on a phase 1 trial of photodynamic therapyPeter H Ahn, Jarod C Finlay, Shannon M Gallagher-Colombo, et al.
Cancer Research|February 13, 2007
Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretionBrian J Czerniecki, Gary K Koski, Ursula Koldovsky, et al.
Cancer Chemotherapy and Pharmacology|January 25, 2018
A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancerJacob E Shabason, Jerry Chen, Smith Apisarnthanarax, et al.
British Journal of Cancer|October 16, 2018
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumoursAmit Maity, Rosemarie Mick, Alexander C Huang, et al.
Pageof 12